Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. [PDF]
, 2008 In the high malaria-transmission settings of sub-Saharan Africa, malaria in pregnancy is an important cause of maternal, perinatal and neonatal morbidity.
Chandramohan, Daniel +11 more
core +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
A cross-sectional study of 'yaws' in districts of Ghana which have previously undertaken azithromycin mass drug administration for trachoma control. [PDF]
, 2015 Yaws, caused by Treponema pallidum ssp. pertenue, is reportedly endemic in Ghana. Mass distribution of azithromycin is now the cornerstone of the WHO yaws eradication campaign.
Anthony W Solomon +50 more
core +1 more source
Prevalence of trachoma at sub-district level in Ethiopia : determining when to stop mass azithromycin distribution [PDF]
, 2014 To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts.
Cromwell, Elizabeth A. +74 more
core +1 more source
When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. [PDF]
, 2009 BACKGROUND: Repeated mass azithromycin distributions are effective in controlling the ocular strains of chlamydia that cause trachoma. However, it is unclear when treatments can be discontinued. Investigators have proposed graduating communities when the
Jeremy D Keenan +39 more
core +2 more sources
Mass treatment with azithromycin for trachoma control: participation clusters in households. [PDF]
, 2010 BACKGROUND: Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential ...
Edwards Tansy +36 more
core +1 more source
Australian Prescriber, 2015 Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and excellent tissue penetration. It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used in preference to other macrolides for some sexually transmitted and enteric infections.
Brendan J, McMullan, Mona, Mostaghim
openaire +2 more sources
Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020.
PLoS ONE, 2022 BackgroundDuring the initial phase of the COVID-19 pandemic, there was great enthusiasm for the use of azithromycin with or without hydroxychloroquine.ObjectivesWe analyzed azithromycin consumption in Croatia in 2020 and compared this to the period 2017 ...
Nikolina Bogdanić +4 more
doaj +1 more source
The Concomitant Use of Azithromycin in Clinical Disease Management [PDF]
E3S Web of ConferencesAzithromycin, an extensively used second-generation macrolide antibiotic, has been prevalent in the management of a wide range of bacterial infections.
He Xinhang
doaj +1 more source
Periodontology 2000, EarlyView., 2023 Abstract This narrative review summarizes the collective knowledge on periodontal microbiology, through a historical timeline that highlights the European contribution in the global field. The etiological concepts on periodontal disease culminate to the ecological plaque hypothesis and its dysbiosis‐centered interpretation.
Georgios N. Belibasakis +5 more
wiley +1 more source